Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index; 22 of the 67 sources its claims cite were checked for support.

Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements

Open access

Abstract

Testosterone boosters (TB) are multi-ingredient dietary supplements that have gained popularity among athletes and the general population. However, certain ingredients in TB are associated with adverse events. The aim of the present study was to analyze dietary TB supplements available for sale online on shop.bodybuilding.com and amazon.com in ten distribution area markets. We evaluated the top five best-selling TB and the most frequently used ingredients of 50 selected TB and the evidence for their efficacy and safety, as well as legislation, statements in the European Union (EU) and sports organizations such as International Olympic Committee (IOC), International Society of Sports Nutrition (ISSN), Australian Institute of Sport (AIS) and World Anti- Doping Agency (WADA). Among 50 TB, 361 components and 98 ingredients were identified. The following ingredients were included in the final review: fenugreek, D- aspartic acid (DAA), 3,3′-diindolylmethane (DIM) or indole-3-carbinol (I3C), Eurycoma longifolia, Cordyceps spp., and ecdysteroids. In EU an authorized health claims refer to few ingredients in TB, mainly minerals, vitamins. Some ingredients were recognized by international sports organizations such as the ISSN, AIS, and WADA and some were identified as unauthorized ingredients/novel food in the EU. Selected ingredients can possibly increase the risk of endocrine system dysregulation.

Overview

CoChat Summary

TL;DR

This review analyzed 50 best-selling testosterone booster (TB) dietary supplements from online markets and evaluated selected ingredients for ergogenic effects, safety, and regulatory status. It found limited or inconsistent human evidence for most reviewed ingredients, with label discrepancies and possible endocrine-system risks.

Key findings

  • Across 50 TB supplements, 361 components and 98 different ingredients were identified, averaging 7.22 ingredients per product. The most common ingredients were zinc (64%), Maca (52%), vitamin B6 (50%), fenugreek (46%), *T. terrestris* (32%), DIM/I3C (32%), black pepper (30%), vitamin D3 (28%), magnesium (26%), vitamin B12 (22%), and DAA and *E. longifolia* (20% each).
  • DAA showed positive testosterone effects in only one cited human study (43 participants; 3.12 g/day for 12 days increased testosterone and luteinizing hormone by 42% and 33%), while later studies found no effect; 6 g/day reduced testosterone by 12.5% in one study. DAA was classified as ISSN category III and has no authorized EFSA/EC health claims.
  • Ecdysterone studies were inconsistent: one 10-week trial reported improved anthropometric and performance parameters at 12 mg and 48 mg daily, but the actual capsule content was 6 mg versus 100 mg declared. Ecdysterone is under WADA monitoring and ISSN category III; some ecdysteroid supplements contained undeclared prohibited AAS.
  • *E. longifolia* was reported to increase testosterone in some studies, including 200 mg/day for 4 weeks in late-onset hypogonadism and 600 mg/day for 2 weeks in young men, but the text notes possible effects on estradiol and HPA rather than aromatase inhibition.

Methods

  • Market analysis was conducted from June 16, 2022, to September 16, 2022, using shop.bodybuilding.com and amazon.com across ten distribution markets; searches used “testosterone booster” in English and local languages.
  • Stage I identified the top five best-selling TB per market, selected 50 supplements, and evaluated label compositions; ingredients with at least 10% prevalence were included, while vitamins, minerals, Maca, *Tribulus terrestris*, *Panax ginseng*, and L-arginine were excluded.
  • Stage II searched PubMed over the same period with terms for DAA, ecdysteroids, *Eurycoma longifolia*, indole-3-carbinol/DIM, fenugreek, *Cordyceps*, and related compounds, plus additional Google Scholar records; final reviewed ingredients were fenugreek, DAA, DIM/I3C, *E. longifolia*, *Cordyceps* spp., and ecdysteroids.

Limitations

  • The provided text does not state an explicit limitations section.
  • Evident from the text: supplement composition was based on labels, and the review itself notes label discrepancies and undeclared substances in some ecdysteroid products.
  • Evident from the text: the market analysis was limited to two online retailers and ten markets over a three-month period, and many cited human studies were small, inconsistent, or of poor quality.

Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/87559129.2023.2238055

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

18 Valid · 4 Not valid · 32 Not checked · 20 Own results and interpretations

54 more claims · 13 with their cited sources checked

Create a free account to see all 74 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 144 references

Research works printed but not linked: 11

  1. 10.1056/NEJMOA1206168/SUPPL_FILE/NEJMOA1206168_DISCLOSURES.PDF · doi:10.1056/nejmoa1206168/suppl_file/nejmoa1206168_disclosures.pdf
  2. 10.1152/JAPPLPHYSIOL.00802.2011/ASSET/IMAGES/LARGE/ZDG0011298840007.JPEG · doi:10.1152/japplphysiol.00802.2011/asset/images/large/zdg0011298840007.jpeg
  3. 10.1186/1477-7827-7-120/FIGURES/4 · doi:10.1186/1477-7827-7-120/figures/4
  4. 10.1186/S12970-015-0078-7/TABLES/2 · doi:10.1186/s12970-015-0078-7/tables/2
  5. 10.1007/S00204-019-02490-X/FIGURES/6 · doi:10.1007/s00204-019-02490-x/figures/6
  6. 10.1186/S12970-020-00390-5/SUPPL_FILE/RSSN_A_12130197_SM0008.DOCX · doi:10.1186/s12970-020-00390-5/suppl_file/rssn_a_12130197_sm0008.docx
  7. 10.1007/S11419-019-00504-Y/FIGURES/8 · doi:10.1007/s11419-019-00504-y/figures/8
  8. 10.1186/1550-2783-10-28/FIGURES/3 · doi:10.1186/1550-2783-10-28/figures/3
  9. 10.1210/EN.20091028 · doi:10.1210/en.20091028
  10. 10.1158/1055-9965.EPI-13-0645/67686/AM/URINARY-3-3-DIINDOLYLMETHANE-A-BIOMARKER-OF · doi:10.1158/1055-9965.epi-13-0645/67686/am/urinary-3-3-diindolylmethane-a-biomarker-of
  11. Jędrejko, K.; Lewandowska-Pachecka, S.; Muszyńska, B. Selected Substances Such as Potential or Proven Ergogenic Aid. Med. Sport. 2021, 22(2).

Cited by

See all 4

Metadata

Authors
Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B.
Affiliations
  • Jagiellonian University (PL)
  • Mount Sinai Hospital (CA)
Corresponding author
Muszyńska, Bożena
Venue
Food Reviews International
Published
2023-10-16
Volume
40
Issue
7
Pages
1825-1853
ISSN
  • 1525-6103 (ISSN-L)
  • 8755-9129
OpenAlex
W4387671680
Cited by
4
References
144
Citations by year
2026: 1 · 2025: 3
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Food Reviews International (publishedVersion, cc-by)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
Funders
no external funding
Topics
  • Social Sciences › Sociology and Political Science › Doping in Sports
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
Keywords
dietary supplements, supplement ingredients, ergogenic aids, supplement safety, endocrine disruption, fenugreek, D-aspartic acid, 3,3'-diindolylmethane, indole-3-carbinol, Eurycoma longifolia, Cordyceps, ecdysteroids, health claims, novel foods, doping regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements. https://app.cochat.ai/papers/10.1080/87559129.2023.2238055
The paper
Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B. (2024). Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements. Food Reviews International. https://doi.org/10.1080/87559129.2023.2238055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.